Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-004983-56Phase 4Completed
Phase 4, randomised, double-blind trial in ischemia-reperfusion injury (IRI) comparing Atorvastatin arm with Placebo arm (2 arms). Primary endpoint: Systemic and cellular markers of ischaemia reperfusion injury at 24 hours. Started Feb 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-004983-56.